Saturday, 24 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Shanghai Duoning Biotechnology Partners with Branca Bunús for Transfection Reagents Innovation
CompanyDeals

Shanghai Duoning Biotechnology Partners with Branca Bunús for Transfection Reagents Innovation

November 6, 2024
NMPA Draft Proposal Aims to Strengthen Supervision of Drug Entrusted Manufacturing
Policy / Regulatory

NMPA Draft Proposal Aims to Strengthen Supervision of Drug Entrusted Manufacturing

November 6, 2024
Asieris Pharmaceuticals Receives NMPA Approval for Hexvix (APL-1706) in Bladder Cancer Diagnosis
CompanyDrug

Asieris Pharmaceuticals Receives NMPA Approval for Hexvix (APL-1706) in Bladder Cancer Diagnosis

November 6, 2024
Frontier Biotechnologies Inc. Gets NMPA Approval for Phase II Study of Albuvirtide as HIV Therapy
CompanyDrug

Frontier Biotechnologies Inc. Gets NMPA Approval for Phase II Study of Albuvirtide as HIV Therapy

November 6, 2024
Fresenius Medical Care Reports 2% YOY Revenue Decrease in 2024 Q3 Financial Results
Company

Fresenius Medical Care Reports 2% YOY Revenue Decrease in 2024 Q3 Financial Results

November 6, 2024
Beijing Mabworks Biotech's IPO Application Accepted by Beijing Stock Exchange
CompanyDeals

Beijing Mabworks Biotech’s IPO Application Accepted by Beijing Stock Exchange

November 5, 2024
Takeda Reports 5% YOY Revenue Growth and Upgrades Forecasts for Fiscal 2024
Company

Takeda Reports 5% YOY Revenue Growth and Upgrades Forecasts for Fiscal 2024

November 5, 2024
Windtree Therapeutics Secures Hong Kong Patent for Istaroxime Heart Failure Treatment
CompanyDrug

Windtree Therapeutics Secures Hong Kong Patent for Istaroxime Heart Failure Treatment

November 5, 2024
BMS's Opdivo Secures NMPA Approval for Urothelial Carcinoma Treatment
CompanyDrug

BMS’s Opdivo Secures NMPA Approval for Urothelial Carcinoma Treatment

November 13, 2024
Boston Scientific Corporation Announces Acquisition of Cortex, Inc.
CompanyDeals

Boston Scientific Corporation Announces Acquisition of Cortex, Inc.

November 5, 2024
China's NMPA Issues Guidelines for Domestic Manufacturing of Imported Medical Devices
Medical DevicePolicy / Regulatory

China’s NMPA Issues Guidelines for Domestic Manufacturing of Imported Medical Devices

November 5, 2024
Legend Biotech Corporation Appoints Alan Bash as President of Carvykti
Company

Legend Biotech Corporation Appoints Alan Bash as President of Carvykti

November 13, 2024
1 2 … 26 27 28 29 30 31 32
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up